CopyMark Law Group
4.9/5
Drawing for INNOBODY

USPTO serial 79275764

INNOBODY

Reviewed by CopyMark Law Group

Reg. 6121389Status 700Renewal
Filing date
Status date
Registration date
Aug 11, 2020
Examiner
COLLOPY, DIANE PATRICIA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INNOBODY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew T. Rissler

Andrew T. Rissler Patel & Almeida, P.C.16830 Ventura Blvd. #360Encino, CA 91436UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Biochemical medicines for the treatment of cancer; dietetic foods adapted for medical use; biological preparations for veterinary purposes for the treatment of infection; pharmaceutical preparations for the treatment of gastrointestinal disorders; vaccines; drugs for medical purposes for the treatment of fever; biological preparations for medical purposes for the treatment of osteoporosis; medicines for human purposes for the treatment of tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, genetic diseases, and for anti-virus; diagnostic preparations for medical purposes; Injectable medicine for treating tuberculosisACTIVE—
042Technological research in the field of immunotherapy; scientific laboratory services; conducting technical project studies in the field of vaccine design; chemical research; Research in the field of chemistry; biological research; bacteriological research; Conducting clinical trials for others; scientific research; research and development of new products for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 11, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 26, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 4, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 3, 2020FIMPFINAL DISPOSITION PROCESSED—
Nov 11, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 11, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 26, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 26, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 6, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 16, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 16, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 15, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 15, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 15, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 15, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 15, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 15, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 15, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 10, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 24, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 24, 2020RFRRREFUSAL PROCESSED BY MPU—
Mar 4, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 3, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2020DOCKASSIGNED TO EXAMINER—
Jan 14, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 8, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 2, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance